Viz.ai Raises Funds to Expand AI-Driven Intelligent Care Coordination Beyond Stroke

March 17, 2021—Viz.ai, which is focused on artificial intelligence (AI)–driven modern care coordination, announced that it has raised $71 million in Series C funding, which will support the company’s aim to accelerate expansion of its Intelligent Care Coordination AI platform beyond stroke to other areas of acute care, such as cardiology, pulmonary, and trauma, and into new global markets.

Viz.ai’s mission is to improve how health care is delivered through intelligent software that promises to reduce time to treatment, improve access to care, and increase the speed of diffusion of medical innovation. Viz.ai’s flagship product, Viz LVO, leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat.

According to Viz.ai, its Intelligent Care Coordination system, which is clinically validated for stroke, brings synchronized collaboration, integrated data, automated processes, and improved visibility to a unified platform with an advanced mobile experience.

The company noted that the largest real-world multicenter study using Viz LVO found a median time to notification of 5 minutes and 45 seconds across all of the sites involved when using the system to identify large vessel occlusions (LVOs).

In the study, which contains the largest health AI data set to date, Viz LVO achieved 96% sensitivity and 94% specificity in identifying LVOs in 2,544 consecutive patients from 139 hospitals using scanners from multiple manufacturers. Faster triage with Viz LVO enables the identification and triage of more patients who are eligible for thrombectomy, which not only improves patient outcomes and reduces disability but also is reimbursed at approximately three times the rate of medically managed stroke.

This round brings the company’s total funding to more than $150 million since inception. The financing round is led by Scale Venture Partners and Insight Partners with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors, and Susa Ventures.

“This expansion addresses the gap in the coordination of care among clinicians and health care systems to best facilitate essential and timely patient care,” commented Rory O’Driscoll, Partner, Scale Venture Partners, in the announcement. “Viz.ai has proven its ability to transform care coordination in stroke by leveraging AI and advanced mobile technology, and we see huge potential for this platform to transform other acute care specialties across health care.”

Nikhil Sachdev, Managing Director, Insight Partners, added, “Viz.ai has taken an innovative approach to transforming one of health care’s biggest challenges, using intuitive technology to help improve patient outcomes in acute care. We see the company poised for massive growth as it scales its clinically verified stroke care coordination system to other use cases where time is crucial to outcomes and costs to patients and hospitals can exponentially increase when care coordination breaks down. We are looking forward to rolling up our sleeves and helping Viz.ai scale up.”

Finally, Chris Mansi, Cofounder and Chief Executive Officer of Viz.ai, stated, “This latest round of funding validates the potential of Viz.ai’s technology, both in and beyond stroke care coordination. The investment will allow us to expedite our effort to bring the power of AI and advanced mobile technology to prevent care breakdowns, improve patient outcomes and experience, and improve economics across the entire health system both in the United States and Europe.”